Dasting.
>Klaus Schwab
>Is it comms for granted a deal to keep legacy intact, and encourages others to get vaxed to preserve "their" legacy?
I don't know, but it's bullshit to preserve any pedophile's "legacy" IMO.
I thought this movement was about truth. I understand that deals can be made and such to get access to more criminals, but if we have the goods on everyone… we should be in a stronger position to bargain than preserving legacies of pedos.
Checked
>Simple case of "Don't push me." turned into "Fuck with me and find out."
There are a lot of Americans who are at this point already.
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
Published Wed, Mar 23 20227:00 AM EDT
LONDON — AstraZeneca said Wednesday it has invested inHuma, a U.K.-based medical technology start-up, as part of a broader commercial tie-up between the two firms.
The British pharmaceuticals giant has taken a roughly ÂŁ25 million ($33 million) stake in Huma, according to a person familiar with the matter. The person preferred to remain anonymous discussing commercially sensitive information.
As part of the deal,Humawill also acquireAMAZE, a disease management platform developed by AstraZeneca for asthma and heart failure patients, the person said.
AstraZeneca and Huma declined to comment on the financial terms of their agreement.
“AstraZeneca will become a shareholder of Huma continuing its mission to build strategic partnerships across the healthcare ecosystem,” an AstraZeneca spokesperson told CNBC.
“We will collaborate closely to scale AMAZE across multiple projects driving our shared ambition to improve clinical outcomes through digital health solutions that bridge the gap between patients, clinicians, and researchers.”
Huma develops applications that let doctors monitor a patient’s symptoms and vital signs remotely. It also collects health data using smartphones, wearables and other devices to help clinicians with conducting medical research involving patients.
AstraZeneca already works with Huma on carrying out clinical trials virtually by using the company’s technology. With its new partnership, Huma aims to become the “extended digital health arm” of AstraZeneca, CEO and co-founder Dan Vahdat told CNBC.
https://www.cnbc.com/2022/03/23/astrazeneca-takes-stake-in-health-tech-start-up-huma.html